Balyasny Asset Management’s Carisma Therapeutics CARM Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-3,534	Closed	-$30K	–	2354
2022 Q3	$30K	Buy	3,534 +1,840	+109%	+$15.6K	﹤0.01%	2043
2022 Q2	$27K	Buy	+1,694	New	+$27K	﹤0.01%	1993
2021 Q2	–	Sell	-2,185	Closed	-$114K	–	1704
2021 Q1	$114K	Buy	+2,185	New	+$114K	﹤0.01%	1445